1. THU0159 Disease Activity Assessment Using the DAS28, CDAI and SDAI and Effect of Anti-Drug Antibody on Clinical Response in a Randomized, Double-Blind, Comparative Trial of CT-P13 and Innovator Infliximab: Planetra Study. (10th June 2014) Authors: Yoo, D.-H.; Park, W.; Brzosko, M.; Géher, P.; Andersone, D.; Jaworski, J.; Rekalov, D.; Oparanov, B.; Kausiene, R.; Pacheco-Tena, C.; Lee, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗